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ABSTRACT
EAST syndrome is a recently described autosomal recessive disorder secondary to mutations in
KCNJ10 (Kir4.1), a gene encoding a potassium channel expressed in the brain, eye, ear and kidney.
This condition is characterized by 4 cardinal features; Epilepsy, Ataxia, Sensorineural deafness, and
(a renal salt-wasting) Tubulopathy, hence the acronym EAST syndrome. Here we review reported
clinical manifestations, in particular the neurological signs and symptoms which typically have the
most impact on the quality of life of patients. In addition we review the pathophysiology and
genetic aspects of the disease. So far 14 different KCNJ10 mutations have been published which
either directly affect channel function or may lead to mislocalisation. Investigations of the








EAST syndrome is an autosomal recessive disorder
characterized by the tetrad of Epilepsy, Ataxia, Senso-
rineural deafness, and (a renal salt-wasting) Tubulop-
athy. It was ﬁrst described as a distinct clinical entity
in 2009 by 2 independent groups, who named this
condition EAST syndrome and SeSAME syndrome
(for Seizures, Sensorineural deafness, Ataxia, Mental
retardation and Electrolyte imbalance), respectively.1,2
However, the ﬁrst clinical description may have been
16 y earlier by White et al.,3 who reported a patient
with epilepsy, sensorineural deafness, ataxia, mental
retardation and a salt-wasting tubulopathy in addition
to oculocutaneous albinism. So far 26 patients have
been reported, in whom mutations in the underlying
gene KCNJ10 (also known as Kir4.1) have been identi-
ﬁed.1,2,4-8 This gene encodes a potassium channel. In
human kidney, it locates in the distal nephron’s baso-
lateral membrane and defective function of this potas-
sium channel leads to impaired distal salt
reabsorption.1,2,8 The biochemical phenotype thus
resembles Gitelman syndrome, another salt-losing
tubulopathy of the distal convoluted tubule, and
potentially also Bartter syndromes which are due to
defective salt transport in the thick ascending limb of
the loop of Henle.9-11 Normotensive hypokalaemic
metabolic alkalosis is the shared ﬁnding in these salt-
wasting renal tubulopathies which are all inherited in
an autosomal recessive manner.1,2,12 A key distin-
guishing feature between these conditions and EAST
syndrome are the additional extrarenal manifestations,
especially of the neurological system in the latter.4
There is phenotypic heterogeneity as the spectrum
and severity of symptoms varies across identiﬁed
EAST syndrome cases and there is also intrafamilial
variability as observations in families with more than
one affected member illustrate the phenotypic vari-
ability that can be seen even within the same kindred
with the same mutation.7 There is no cure for this
condition and management is focused on controlling
seizure activity and on salt supplementation.1,2,4,7
Clinical features
Neurological features
The neurological aspects are the most debilitating fea-
tures of EAST syndrome and have the most impact on
the quality of life of affected patients. While severity
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can vary, in some patients the ataxia dramatically lim-
its the ability of both oral and written communication,
leading to enormous frustration of these patients and
a potentially mistaken diagnosis of mental retardation.
The acronym SeSAME, which makes mental retarda-
tion a deﬁning feature of the disease, is thus problem-
atic. Not only has the term “mental retardation” been
replaced in the United States by “intellectual disabil-
ity” (“Rosa’s law”) (Pub. L. 111-256), but the difﬁculty
of properly assessing intelligence in these patients may
label them with this stigmatizing term undeservedly.
Detailed descriptions of neurological abnormalities,
including brain imaging and electrophysiological
investigations, have been reported in patients with
conﬁrmed EAST syndrome.1,2,4,7 Typically, patients
were born after uncomplicated pregnancies and with
normal birth weights by normal vaginal deliveries at
term. The majority were initially well with an unevent-
ful neonatal period and ﬁrst presentation to hospital
was typically in the ﬁrst few months of life either due
to seizure activity, failure to thrive or an intercurrent
illness with incidental biochemical abnormalities sug-
gestive of a tubulopathy.4
Epilepsy
Seizures are typically infantile in onset with the ﬁrst ﬁt
usually occurring between 3 to 9 months of age; how-
ever, there are reports of a possible episode in the neo-
natal period.4,7 These generalized seizures, which may
be primary or secondary generalized seizures, were
mostly easily controlled by a broad-spectrum anticon-
vulsant. In our review of affected children seen at
Great Ormond Street Hospital, around half of the chil-
dren were seizure free later on in childhood and ado-
lescence and the other half subsequently developed
focal seizures or continued to have tonic-clonic seiz-
ures when unwell.4 Two of the patients also experi-
enced non-convulsive and convulsive status
epilepticus and there is reporting of a child developing
a prolonged seizure activity resulting in a right-sided
hemiparesis.4,7 Seizure activity was controlled by a
range of different anticonvulsants such as carbamaze-
pine, oxcarbazepine, sodium valproate, lamotrigine,
phenobarbital, phenytoin and diphenylhydantoin,
however in a proportion of these children there was
drug-resistant seizures of evident focal onset.2,4,7
Epileptic seizures were reported in all EAST
patients studied except for 2 cases. Both these patients
were homozygote for the KCNJ10 mutant p.A167V
which experimentally has been shown to have around
60% residual activity.6 They did however both have
hearing impairment and tubulopathy, so the apparent
lack of seizure activity in these patients raised interest-
ing questions on organ speciﬁc effects of this mutation.
Yet, another patient homozygote for the p.A167V
exhibited the full spectrum of symptoms, including
epilepsy and ataxia, raising the possibility that the epi-
leptic activity in the other 2 patients may have not
been picked up due to infrequency or subtlety.6,13
Ataxia and cerebellar dysfunction
All of the children, who were old enough to have their
cerebellar function assessed, presented with cerebellar
dysfunction with varying severity and impediment of
their daily activities.2,4,7 In those that could walk, cere-
bellar dysfunction presented as characteristic broad-
based ataxic gait, which resulted in unsteadiness and
falls. Ataxia presented early in the majority of cases
and was evident from when they were learning to
walk, suggesting that ataxia from the outset is a feature
of EAST syndrome. Other cerebellar signs include
intention tremor, dysdiadochokinesis, dysmetria,
truncal ataxia, titubation and slurred and scanning
(explosive) speech.4,7 Nystagmus appears to be an
infrequent feature in these patients and has so far
been only documented in one case.7 There seems to be
heterogeneity in muscle tone among EAST syndrome
patients. Only one of the studies, which have described
the clinical features in EAST syndrome cases, reported
hypotonia as a shared feature of 4 patients who were
referred for evaluation of Gitelman and Bartter syn-
dromes and later found to have KCNJ10 mutations.2
Tone was more commonly reported as increased,
either generally or exclusively in the lower limbs with
a suggestion that there is increasing tone with age.4,7
Other upper motor neuron signs exhibited included
exaggerated deep tendon reﬂexes, ankle clonus and
extensor plantar responses.4,7 There were also reports
of dystonic posturing in the upper limb and face in
older patients.4
Developmental delay and intellectual disability
Some form of neurodevelopmental delay was evident
in most patients that were old enough to be assessed.
Typically, there is delayed attainment of motor mile-
stones with delays in sitting unsupported, walking
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aided or walking independently.2,4,7 Two children
were never independently ambulant due to the sever-
ity of their ataxia.4 In those that were able to walk, the
age to acquire this skill ranged from around 17
months to 7 y.4,7 EAST syndrome appears to be static
or non-progressive in nature with no regression in
attained milestones, however one patient who walked
independently within the normal developmental time
frame later lost the ability to walk after a prolonged
ﬁt.4 This is likely to be the result of brain hypoxia
from the prolonged seizure and not directly due to the
KCNJ10 mutation. Another case was evaluated on sev-
eral occasions due to apparent regression in develop-
ment however it is not clearly documented, whether
there was actual loss of previously attained mile-
stones.7 There also appears to be phenotypic variabil-
ity among siblings with EAST syndrome with regards
to their motor development. In a family with 3
affected children, one sibling was able to walk at
around 3.5 y of age, another at around 7.5 y and more
unsteady, and another unable to walk independently
at all4 With regard to language development, apart
from the slurred speech and scanning dysarthria suf-
fered by some patients, indicators of cerebellar disease,
delayed onset of speech especially the ability to talk in
full sentences was a common ﬁnding.2,4,7
Intellectual disability, as discussed above, can be
difﬁcult to properly assessed due to the impaired com-
munication in severely affected patients. In our experi-
ence, there are clearly patients without intellectual
disability who attend mainstream schools without spe-
cial support, but these are a minority. Detailed neuro-
psychological assessments have not been undertaken
in all patients with KCNJ10 mutations, but most
patients do require special support in school.4,14
Neuroimaging and electrophysiological
investigations
In the majority of cases, MRI of the brain detected
pathological ﬁndings although normal brain MRI
were reported in some.1,2,4,7 However, on careful
review of a cohort of children with EAST syndrome
subtle changes in MRI were detected, that were previ-
ously reported as normal. This highlights the difﬁcul-
ties of interpreting such subtle ﬁndings as normal
variant or related to disease pathology when only seen
in an isolated case.1,4 Importantly, automated regional
quantitative volumetric analysis of the images showed
a pattern of variation from the norm involving com-
paratively smaller temporal cortical and larger frontal
cortical regions. Such automated analysis may thus
provide an alternative and potentially more objective
approach to identify minor imaging abnormalities,
especially in rare disease, where the radiologist is
unlikely to see cohorts of patients.15
Identiﬁed aberrations on radiological review varied
in severity as well as location, however, the majority
showed abnormalities of the cerebellum which
included subtle signal changes in the cerebellar den-
tate nuclei and cerebellar hypoplasia.4 These changes
are in keeping with ataxia, a manifestation of cerebel-
lar dysfunction. Repeated MRI scans were conducted
in 2 patients and these showed no evidence of any
progressive changes supporting the concept that
EAST syndrome is static.
Unlike brain MRI, almost all EEG that were con-
ducted were unremarkable with no epileptiform dis-
charges.1,2,4,7 In one patient, there were localized
spikes and sharp waves with slow activity with a sub-
sequently normal EEG performed at later stage.4 An
electroencephalographic recording in another case
revealed occasional sharp activity over one hemi-
sphere with a slow and disorganized background with
focal slowing. Yet the recording was reportedly carried
out after a prolonged seizure that left the patient with
a right sided weakness and subsequently more fre-
quent seizures. Thus, the abnormal EEG activity could
have been a consequence of the prolonged seizure,
consistent also with the development of new MRI
changes in that same patient in the form of a new
lesion with restricted diffusion in the parietal area,
which was deemed to be excitopathic.7
Electromyographic recordings were normal, as well
as muscle biopsies when tested.1 Nerve conduction
studies on EAST patients were also normal except in
one patient who was reported to have diminished
nerve conduction velocities in the left peroneal and
left tibial nerves. Nerve biopsy in the same patient
revealed hypomyelination of the sural nerve with
moderate progressive axonal neuropathy.2 Interest-
ingly, central myelination appeared normal on mag-
netic resonance imaging in the same patient.
Hearing impairment
Sensorineural deafness is a consistent feature found in
those with EAST syndrome.16 All cases, in whom
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hearing assessment could be undertaken, presented with
some degree of hearing impairment except one case,
who showed grossly normal hearing on audiometry and
further audiological investigations were not docu-
mented.1,2,4,7 Severity of hearing impairment is variable
from mild, in some cases undiagnosed until formal test-
ing was undertaken as part of the study, to severe, neces-
sitating bilateral hearing aids.4 Importantly, in those
patients where serial hearing tests were available, no pro-
gression of the impairment was noted.4
Renal
From a nephrological perspective EAST syndrome is
very similar to Gitelman syndrome as biochemically
there is hypokalaemic metabolic alkalosis, hypomag-
nesaemia and hypocalciuria as well as activation of
the renin-angiotensin-aldosterone axis and loss of
urinary sodium, potassium, chloride and magne-
sium. Both these conditions are the result of defec-
tive electrolyte transport in the distal convoluted
tubule.1,2 In the majority of cases initial clinical pre-
sentation of this potassium channel defect is due to
neurological symptoms (see above) with the bio-
chemical aspects of this syndrome generally often
noted only later in childhood. These observations
argue that the etiology of the seizures is an intrinsic
consequence of KCNJ10 dysfunction in the brain
and not a secondary complication of electrolyte
imbalance. However, biochemical abnormalities,
especially hypokalaemic alkalosis have been reported
already in infancy in some patients.2,4,7
Other symptoms suggestive of renal salt wasting
include salt craving, polydipsia, polyuria and enure-
sis.2 In our own experience, polydipsia and polyuria
are rare, with most patients able to concentrate their
urine normally, as evidenced by random urine osmo-
lalities well above 800 mosm/kg. Blood pressure is typ-
ically low or at the lower range of normal.1 Impaired
growth and failure to thrive appears to respond well to
medical management with salt supplementation and
nutritional support. However, short stature as well as
weight and head circumference measurements that
were low for age and sex were reported later on in life
in a few of the cases.2,4
There is variability in the degree of electrolyte dis-
turbance among those with EAST syndrome, includ-
ing variability within families. In some cases there is
an incidental mild hypomagnesemia with no other
biochemical disturbance and others with a more typi-
cal Gitelman-like abnormality of their electrolytes.
Serial electrolyte measurements may reveal worsening
and progression of the biochemical disturbance with
age. In a particular study focused on the renal facets
of KCNJ10 mutations, there was a statistically signiﬁ-
cant effect of age on bicarbonate and potassium lev-
els.7 While serum bicarbonate levels increase and
serum potassium decreases normally with age, in
these patients, the evolving changes were noticeably
greater than the expected physiological change. Bicar-
bonate levels are usually normal in the ﬁrst few years
of life followed by a rapid increment until around
age 6 y with subsequent plateauing. There was insuf-
ﬁcient data on magnesium levels to draw a conclu-
sion on its progression [7]: in some patients renal
magnesium loss became evident later on in life
whereas in others hypomagnesaemia has been
detected as early as the ﬁrst year of life. Oral sodium,
potassium or magnesium supplementation is pre-
scribed in almost all cases where serum levels were
found to be low.1,2,4,7 In attempt to normalize serum
potassium levels, potassium sparing diuretics have
been used in some patients. However such diuretic
treatment compounds the renal salt loss and thus
may put patients at risk of potentially life threatening
hypovolemia.4,7
When urine was tested, 24-hour urine sampling
detected renal potassium and magnesium wasting, low
urinary calcium-creatinine ratio and elevated 24-hour
urinary aldosterone.2,4,7 There was no proteinuria or
glycosuria. Spot urine osmolality, a measure of the
ability to concentrate urine, was frequently within
high normal limits, attesting to non-compromised uri-
nary concentrating ability. When measured, plasma
renin activity (PRA) and aldosterone were always ele-
vated.1 Other serum electrolyte disturbances found
rarely in patients with EAST syndrome included
reduced serum sodium and chloride.4,7
Ultrasound examination of kidneys typically shows
no abnormalities.1 Moreover, in one patient with
EAST syndrome, in whom a renal biopsy had been
performed, careful electron microscopic examination
revealed ultrastructural changes in the distal tubule
with decreased basolateral infolding and a reduced
number of mitochondria, as a morphological correlate
to the impaired transport capacity in this segment.8
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Pathophysiology
Neurological
Seizure activity may be explained by a process called
potassium spatial buffering which is a mechanism that
dictates the resting potential of neurons.17-19 When
excitation and repolarization occurs repeatedly there
is considerable neuronal inﬂux of sodium as well as
potassium efﬂux and thus extracellular potassium
build-up. This decreases the membrane potential ren-
dering it susceptible to further excitations and so a
predilection for seizure activity. It is thought that the
excess extracellular potassium is taken up by glial cells
via KCNJ10 potassium channels and subsequently dis-
tributed through gap junctions to minimize the risk of
excessive excitability.17-20 Thus any functional defect
of KCNJ10 would disrupt this protective potassium
“siphoning” and could explain why epilepsy is a cardi-
nal feature of EAST syndrome.1,21 The removal and
redistribution of potassium by KCNJ10 also appears
to occur in the M€uller glia cells of the retina, which
has been observed experimentally in mice.22 It is likely
that KCNJ10 mutations impair the function of M€uller
cells also in humans as electroretinographic recordings
in 4 EAST patients were reported as abnormal.23
Inner ear
In mice Kcnj10 is expressed in the intermediate cells
of the stria vascularis of the inner ear, where they con-
tribute to the rich potassium content of the endo-
lymph.24 These processes are imperative for the
hearing mechanism as they facilitate potassium entry
into the cochlear hair cells, which is needed for signal
transduction.24,25 This explains why hearing
impairment is a feature of patients with EAST syn-
drome and why there is severe hearing loss in Kcnj10
knockout mice.1,2,16,24,26
Renal
One of the major roles of the kidneys is to maintain
homeostasis of water, electrolytes and acid-base bal-
ance. KCNJ10 is a potassium channel located distal to
the macula densa, in the distal convoluted tubules,
connecting tubules and collecting ducts.27,28 These
structures, which are in the latter part of nephron,
contribute to ﬂuid and electrolyte balance and regulate
pH through reabsorption of sodium, potassium, mag-
nesium, calcium, and excretion of potassium and
hydrogen ions by energy dependent transcellular
transport. These processes are regulated by hormones,
most prominently aldosterone.29,30
The distal convoluted tubule and connecting
tubule are characterized by numerous infoldings of
their basolateral plasma membrane, where KCNJ10
potassium channels reside, as well as an increased
number of mitochondria and NaC/KC-ATPases, all
of which reﬂects the high transport activity in this
segment.31 In these parts of the nephron as well as
cortical thick ascending limb, where KCNJ10 is
expressed, this potassium channel is responsible for
potassium conductance and necessary for a process
called pump-leak coupling.8,32,33 According to this
hypothesis, which was ﬁrst proposed in 1958, the
activity of NaC/KC-ATPase in epithelia, across which
there is a high rate of transport, is rate limited by the
availability of potassium outside the cell. Because of
this constraint, potassium recycling is required and
this process occurs at the basolateral membrane via
potassium channels such as KCNJ10. In this way,
KCNJ10 potassium channels and other potassium
channels generate a hyperpolarized membrane volt-
age which facilitates ion transport that is voltage
dependent such as sodium inﬂux and chloride
efﬂux.1,8,31,34 The renal phenotype of EAST syndrome
due to KCNJ10 mutations is thus a result of an
impairment of this process: the reduced potassium
recycling affects NaC/KC-ATPase activity which con-
sequent reduced transport activity.
Renal loss of sodium chloride results in activation
of the renin-angiotensin-aldosterone axis leading to
increased plasma levels of renin and aldosterone activ-
ity in EAST patients when measured.1 Aldosterone
stimulates sodium reabsorption by amiloride-sensitive
epithelial sodium channels (ENaC), which are present
on the apical membrane of the late distal convoluted
tubule and connecting tubule. This sodium reabsorp-
tion, a compensatory mechanism to minimize the
renal sodium wasting, is accompanied by potassium
and hydrogen ion secretion in urine resulting in the
hypokalaemic metabolic alkalosis found in patients
with EAST syndrome.31
A characteristic feature seen in EAST syndrome, as
well as other conditions with defective function of the
distal convoluted tubule such as Gitelman syndrome,
is the reduced absorption of magnesium in the distal
convoluted tubule resulting in hypermagnesiuria
and hypomagnesaemia, as well as increased calcium
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reabsorption leading to hypocalciuria.35 There are
several proposed mechanisms in the literature to try
to explain why there is renal loss of magnesium and
retention of calcium; however this appears to be still
under debate.31,36
KCNJ10 expression
The clinical phenotype of KCNJ10 mutations corre-
lates with its gene expression in various organs such
as the brain, ear, eye and kidney.1,16,22,24,27,28,37 In the
kidney, KCNJ10 potassium channels and its homolog
KCNJ16 are located within the renal tubules.8,27,28 In
the mouse kcnj10 and kcnj16 channel proteins were
localized by immunoﬂuorescence to the basolateral
membrane of the distal convoluted tubule, connecting
tubule and cortical collecting duct.8 KCNJ potassium
channels are tetramers and thus consisting of 4 subu-
nits. Association of different subunits (heteromers)
can occur and electrophysiological studies on isolated
tubules and cell lines clearly support the idea of
KCNJ10/KCNJ16 heteromers as the predominant in
vivo conductance in the basolateral membrane of the
distal convoluted tubule.8,34,38-41 Thus KCNJ16 consti-
tutes a candidate gene for salt wasting tubulopathies.
As in rodent kidney, where Kcnj10 is expressed pre
and post macula densa,42 there are some data in
human kidney suggesting expression also in the baso-
lateral membrane of cortical thick ascending limb of
Henle’s loop (TAL).8 However, the clinical phenotype
of a Gitelman-like tubulopathy suggests dysfunction
primarily in the DCT, as defective salt reabsorption is
associated with hypercalciuria, i.e. a Bartter-like tubul-
opathy. Whether expression in TAL is too low to
affect the phenotype or whether other potassium
channels can compensate for loss-of-function in this
segment remains to be elucidated.
Studies in mice showed that Kcnj10 is also
expressed in brain astroglia, M€uller cells of the retina
and the stria vascularis of the inner ear where it is
needed for the generation of the endocochlear poten-
tial which is crucial for hearing.22,24 Within the brain
glia, Kcnj10 is expressed predominantly in the cerebral
cortex and cerebellar cortex as well as in the caudate
nucleus and putamen.1,37
KCNJ10mutations
The KCNJ10 gene encodes the KCNJ10 channel, which
is also known as ATP-sensitive inward rectiﬁer potas-
sium channel KIR4.1. It is located on chromosome
1q23.2 and so far 14 different pathogenic KCNJ10
mutations have been described in the literature in cases
with EAST syndrome.1,2,5-8,39,43 EAST syndrome is an
autosomal recessive disorder and all known EAST
patients carry 2 mutant alleles of KCNJ10. As expected
for most autosomal recessive conditions so far there is
no reported symptomology or pathology in heterozy-
gote relatives such as siblings and parents.1,31 Patients
with EAST syndrome either carry the same mutant
allele on each strand of chromosome one and thus are
homozygotes or carry 2 different mutant alleles, one on
Table 1. All known KCNJ10 mutations published to date.
Mutation Pathogenic Inherited State Experimental Residual activity Reference
p.T57I (c.170C>T)  Homozygous missense mutation Loss of function 7
p.R65C (c.193G>C)  Homozygous missense mutation < 20% 5
p.R65P (c.194G>C)  Homozygous missense mutation
 Compound heterozygous missense /
nonsense mutations with p.R199X
< 20% 1,2,8,38,39
p.F75C (c.224T>G)  Homozygous missense mutation Loss of function 6
p.F75L (c.225T>G)  Homozygous missense mutation < 10% 5
p.G77R (c.229G>C)  Homozygous missense mutation < 5% 1,8,39
p.V91fs197 (c.272delT)  Homozygous frameshift mutation Loss of function or < 2%
residual activity
6
p.C140R (c.418T>C)  Homozygous missense mutation Loss of function 2,39,43
p.T164I (c.491C> T)  Homozygous missense mutation Loss of function 2,38,39,43
p.A167V (c.500C>T)  Homozygous missense mutation
 Compound heterozygous missense
mutations with p.R297C
60% 2,6,38,39,43
p.R175Q (c.524G>A)  Homozygous missense mutation < 5% 8
p.R199 (c.595C>T)  Compound heterozygous missense /
nonsense mutations with p.R65P
Loss of function 2,38,39,43
p.V259 (c.775delG)  Homozygous nonsense mutation Loss of function 5
p.R297C (c.889C>T)  Compound heterozygous missense
mutations with p.A167V
< 10% 2,5,38,39,43
e1195043-6 O. ABDELHADI ET AL.
each chromosome, therefore being compound hetero-
zygotes.1,2,5-8 Table 1 shows all known KCNJ10 muta-
tions published to date. Mutations identiﬁed so far are
mainly missense mutations except for p.V259fs259,
R199 (so far only reported in heterozygous state) and
p.V91fs197, which result in the generation of a prema-
ture stop codon.5
Electrophysiological studies in mammalian cells
and Xenopus oocytes showed decreased potassium
conductivity of KCNJ10 channels with mutations
associated with EAST syndrome.1,5-8,38,39,43 All but
one mutation, p.A167V, severely affect the function
with less than 20% residual activity reported and with
complete or near complete loss of function in p.R199,
p.F75C, p.C140R, p.V91fs197, p.V259, p. T57I and
p.T164I.5-7,13,38,39,43 KCNJ10 p.A167V mutations also
reduce potassium conductance, however to a lesser
extent, retaining 60% residual activity.6,38,39 This level
of activity is presumed to be present in unaffected sib-
lings or parents of EAST patients who are heterozy-
gous for this mutation and so initially it was thought
that this mutation was not pathogenic in the homozy-
gote state.38 However homozygotes for this mutation
(p.A167V) have been diagnosed with EAST syndrome
and in our own analysis co-expression of this KCNJ10
mutation with KCNJ16, mimicking the native channel
in kidney showed a dramatic reduction in function,
suggesting that the p.A167V mutation causes reduced
heteromer activity.6 A recent study questions this pro-
posed pathogenic mechanism of p.A167V mutation as
KCNJ10 does not form heteromers in the brain or
ear.13,41,44 Therefore reduced KCNJ10/KCNJ16 het-
eromeric activity may not be the sole pathogenic pro-
cess caused by this mutation as it does not explain the
non-renal symptoms seen in these EAST patients. The
same study suggested experimentally that this p.
A167V mutation causes the KCNJ10 channels to not
be anchored to the basolateral membrane of the renal
epithelia and there is inhibition of expression. This
mistrafﬁcking and thus mislocalisation of KCNJ10
may consequently cause loss of potassium recycling
which is an essential function of the basolateral mem-
brane of the distal nephron segment.13 The divergent
clinical ﬁndings in the 3 patients identiﬁed so far with
homozygous A167V mutations reﬂect this contro-
versy, as 2 patients show predominantly renal mani-
festations (i.e., consistent with the heteromer
hypothesis), whereas the other patient shows the com-
plete EAST phenotype, including the neurological
manifestations (i.e. consistent with the mistrafﬁcking
hypothesis).
Conclusion
The constellation of epilepsy, ataxia, sensorineural
deafness and salt wasting secondary to renal tubulop-
athy is known as EAST syndrome. This phenotype is
consequent to mutations in the KCNJ10 gene, which
is located on chromosome 1 and has an autosomal
recessive mode of inheritance. So far there have been
14 different KCNJ10 mutations described in the litera-
ture and these result in reduced or total loss of func-
tion of the KCNJ10 channel. Expression of KCNJ10
correlates with the clinical and biochemical character-
istics of EAST syndrome with KCNJ10 potassium
channels located in the brain, eye, ear and kidney.
Inadequate potassium clearance by these channels in
glial cells of the brain lowers seizure threshold and
thus epilepsy is a hallmark of EAST syndrome. Neuro-
imaging in most cases revealed changes in their cere-
bellum highlighting cerebellar dysfunction,
manifesting as ataxia, another clinical facet of KCNJ10
mutations. Sensorineural hearing loss is the result of
the failure to generate the endocochlear potential and
high potassium concentration in the endolymph, a
process vital for hearing. The renal salt-wasting seen
in this condition is secondary to defective in potas-
sium recycling and basolateral membrane depolariza-
tion in the distal nephron leading to impaired
transepithelial electrolyte transport.
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